Literature DB >> 9508108

Mathematical model for the epidemiology of tuberculosis, with estimates of the reproductive number and infection-delay function.

E E Salpeter1, S R Salpeter.   

Abstract

The authors used epidemiologic data on tuberculosis to construct a model for the time delay from initial latent infection to active disease, when infection transmission occurs. They used case rate tables in the United States to calculate the fractional rate of change per annum (A) in the incidence of active tuberculosis. They then derived estimates for the effective reproductive number (R) and the cumulative transmission, defined as the number of people whom one infected person will infect in his or her lifetime and over many multiple successive transmissions, respectively. For A of -4 percent per year, the average US condition from 1930 to 1995, they estimate the reproductive number to be about 0.55 and the cumulative transmission to be about 1.2. The estimated rate of the new latent infections in the United States is 80,000 per year, the estimated prevalence of latent infections is 5 percent, and the number of transmissions of infection per active case is 3.5. From the model, the authors predicted active case rates in various age groups and compared them with published tables. The comparison suggests that the risk of activation decreases rapidly, then gradually, for the first 10 years after initial infection; the risk is relatively constant from 10 to 40 years and may decrease again after 40 years. The authors also discuss how this model can be used to help make decisions about tuberculosis control measures in the population.

Entities:  

Mesh:

Year:  1998        PMID: 9508108     DOI: 10.1093/oxfordjournals.aje.a009463

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

Authors:  D Shepardson; S M Marks; H Chesson; A Kerrigan; D P Holland; N Scott; X Tian; A S Borisov; N Shang; C M Heilig; T R Sterling; M E Villarino; W R Mac Kenzie
Journal:  Int J Tuberc Lung Dis       Date:  2013-12       Impact factor: 2.373

2.  Priorities for screening and treatment of latent tuberculosis infection in the United States.

Authors:  Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

3.  Transmissibility of tuberculosis among school contacts: an outbreak investigation in a boarding middle school, China.

Authors:  Mai-Juan Ma; Yang Yang; Hai-Bin Wang; Yi-Fan Zhu; Li-Qun Fang; Xiao-Ping An; Kang-Lin Wan; Christopher C Whalen; Xiao-Xian Yang; Michael Lauzardo; Zhi-Yi Zhang; Jin-Feng Cao; Yi-Gang Tong; Er-Hei Dai; Wu-Chun Cao
Journal:  Infect Genet Evol       Date:  2015-03-07       Impact factor: 3.342

4.  Modeling socio-demography to capture tuberculosis transmission dynamics in a low burden setting.

Authors:  Giorgio Guzzetta; Marco Ajelli; Zhenhua Yang; Stefano Merler; Cesare Furlanello; Denise Kirschner
Journal:  J Theor Biol       Date:  2011-09-03       Impact factor: 2.691

5.  Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  Am J Respir Crit Care Med       Date:  2009-03-19       Impact factor: 21.405

6.  Multivariate Markovian modeling of tuberculosis: forecast for the United States.

Authors:  S M Debanne; R A Bielefeld; G M Cauthen; T M Daniel; D Y Rowland
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

7.  Emergent heterogeneity in declining tuberculosis epidemics.

Authors:  Caroline Colijn; Ted Cohen; Megan Murray
Journal:  J Theor Biol       Date:  2007-04-27       Impact factor: 2.691

8.  The dynamics of evolutionary rescue from a novel pathogen threat in a host metapopulation.

Authors:  Jing Jiao; Nina Fefferman
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

9.  Potential economic viability of two proposed rifapentine-based regimens for treatment of latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  PLoS One       Date:  2011-07-18       Impact factor: 3.240

10.  Strategies for treating latent multiple-drug resistant tuberculosis: a decision analysis.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  PLoS One       Date:  2012-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.